Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C32H46N8O6S2 |
| Molecular Weight | 702.888 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 2 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCC(=O)OCCC(SSC(CCOC(=O)CCC)=C(C)N(CC1=CN=C(C)N=C1N)C=O)=C(C)N(CC2=CN=C(C)N=C2N)C=O
InChI
InChIKey=YMEBNAABDXLAJE-KKTFQPMKSA-N
InChI=1S/C32H46N8O6S2/c1-7-9-29(43)45-13-11-27(21(3)39(19-41)17-25-15-35-23(5)37-31(25)33)47-48-28(12-14-46-30(44)10-8-2)22(4)40(20-42)18-26-16-36-24(6)38-32(26)34/h15-16,19-20H,7-14,17-18H2,1-6H3,(H2,33,35,37)(H2,34,36,38)/b27-21-,28-22+
| Molecular Formula | C32H46N8O6S2 |
| Molecular Weight | 702.888 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 2 |
| Optical Activity | NONE |
DescriptionSources: http://www.google.ch/patents/EP0830862A4?cl=en&hl=deCurator's Comment: Description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/6009073
https://books.google.ru/books?id=0vXTBwAAQBAJ&pg=PA1181&lpg=PA1181&dq=Bisbutythiamin+drug&source=bl&ots=6IVjo2Xxxs&sig=lzsAkD2mgHSQp_9ewYdntzQJ57g&hl=en&sa=X&ved=0ahUKEwjCpdeB7bPPAhVK3SwKHfY6CL0Q6AEIKzAD#v=onepage&q=bisbu&f=false
Retrieved from Dictionary of drugs: Chemical data, structures and bibliographies, edited by J. Elks and C. R. Ganellin. Chapman and Hall, p.1181
Sources: http://www.google.ch/patents/EP0830862A4?cl=en&hl=de
Curator's Comment: Description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/6009073
https://books.google.ru/books?id=0vXTBwAAQBAJ&pg=PA1181&lpg=PA1181&dq=Bisbutythiamin+drug&source=bl&ots=6IVjo2Xxxs&sig=lzsAkD2mgHSQp_9ewYdntzQJ57g&hl=en&sa=X&ved=0ahUKEwjCpdeB7bPPAhVK3SwKHfY6CL0Q6AEIKzAD#v=onepage&q=bisbu&f=false
Retrieved from Dictionary of drugs: Chemical data, structures and bibliographies, edited by J. Elks and C. R. Ganellin. Chapman and Hall, p.1181
BISBUTYTIAMINE is a Vitamin B derivative, analgesic. BISBUTYTIAMINE has being shown to be useful for preventing and treating AIDS, because it has the effect of inhibiting the growth of HIV on early infected cells without killing the cells and both of the cytocidal and HIV-killing effects on the cells that have come to produce HIV continuously.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: HIV growth Sources: http://www.google.ch/patents/EP0830862A4?cl=en&hl=de |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | Unknown Approved UseUnknown |
|||
| Primary | Unknown Approved UseUnknown |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:20:25 GMT 2025
by
admin
on
Mon Mar 31 18:20:25 GMT 2025
|
| Record UNII |
6A8BO41Z90
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C45812
Created by
admin on Mon Mar 31 18:20:25 GMT 2025 , Edited by admin on Mon Mar 31 18:20:25 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
C79880
Created by
admin on Mon Mar 31 18:20:25 GMT 2025 , Edited by admin on Mon Mar 31 18:20:25 GMT 2025
|
PRIMARY | |||
|
CHEMBL2104407
Created by
admin on Mon Mar 31 18:20:25 GMT 2025 , Edited by admin on Mon Mar 31 18:20:25 GMT 2025
|
PRIMARY | |||
|
3286-45-1
Created by
admin on Mon Mar 31 18:20:25 GMT 2025 , Edited by admin on Mon Mar 31 18:20:25 GMT 2025
|
ALTERNATIVE | |||
|
6A8BO41Z90
Created by
admin on Mon Mar 31 18:20:25 GMT 2025 , Edited by admin on Mon Mar 31 18:20:25 GMT 2025
|
PRIMARY | |||
|
76000144
Created by
admin on Mon Mar 31 18:20:25 GMT 2025 , Edited by admin on Mon Mar 31 18:20:25 GMT 2025
|
PRIMARY | |||
|
217882Q07P
Created by
admin on Mon Mar 31 18:20:25 GMT 2025 , Edited by admin on Mon Mar 31 18:20:25 GMT 2025
|
PRIMARY | |||
|
100000076841
Created by
admin on Mon Mar 31 18:20:25 GMT 2025 , Edited by admin on Mon Mar 31 18:20:25 GMT 2025
|
PRIMARY | |||
|
SUB13073MIG
Created by
admin on Mon Mar 31 18:20:25 GMT 2025 , Edited by admin on Mon Mar 31 18:20:25 GMT 2025
|
PRIMARY | |||
|
18481-23-7
Created by
admin on Mon Mar 31 18:20:25 GMT 2025 , Edited by admin on Mon Mar 31 18:20:25 GMT 2025
|
PRIMARY | |||
|
DTXSID901105808
Created by
admin on Mon Mar 31 18:20:25 GMT 2025 , Edited by admin on Mon Mar 31 18:20:25 GMT 2025
|
PRIMARY | |||
|
242-370-8
Created by
admin on Mon Mar 31 18:20:25 GMT 2025 , Edited by admin on Mon Mar 31 18:20:25 GMT 2025
|
PRIMARY |